varenicline has been researched along with Alcohol Abuse in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (10.42) | 29.6817 |
2010's | 28 (58.33) | 24.3611 |
2020's | 15 (31.25) | 2.80 |
Authors | Studies |
---|---|
Donato, S; Green, R; Ray, LA | 1 |
Kalin, NH | 1 |
Andreas, S; Batra, A; Gohlke, H; Kiefer, F; Klein, M; Kotz, D; Mons, U; Mühlig, S; Petersen, KU; Pötschke-Langer, M; Preuss, UW; Rustler, C; Rüther, T; Thomasius, R; Ulbricht, S | 1 |
Bendiks, S; Blokhina, E; Bryant, K; Cheng, DM; Freiberg, MS; Gnatienko, N; Hahn, J; Krupitsky, E; Lioznov, D; Patts, G; Samet, JH; So-Armah, K; Stein, MD; Tindle, HA; Yaroslavtseva, T | 1 |
Enders, CK; Nieto, SJ; O'Malley, SS; Ray, LA; Witkiewitz, K | 1 |
Paitoon, P; Phimarn, W; Sakhancord, R; Saramunee, K; Sungthong, B | 1 |
Deng, X; E, F; Guo, K; Li, X; Liang, S; Liu, W; Shang, X; Wang, Y; Wang, Z; Wu, Y; Yang, K; Zhou, L | 1 |
Cabrera-César, E; de Granda-Orive, JI; De Higes-Martínez, E; García Rueda, M; Jiménez-Ruiz, CA; Pastor-Esplá, E; Rábade-Castedo, C; Ramos-Pinedo, Á; Riesco-Miranda, JA; Signes-Costa Miñana, J | 1 |
Likhitsathain, S; Oon-Arom, A; Srisurapanont, M | 1 |
Gandhi, KD; Karpyak, VM; Kolla, BP; Mansukhani, MP; Schneekloth, TD; Wang, Z | 1 |
Chun, TH; Falk, DE; Fertig, JB; Litten, RZ; Miranda, R; Muvvala, SB; O'Malley, SS; Ryan, ML; Treloar Padovano, H; Wu, R | 1 |
Kenny, PJ; O'Brien, CP; Pierce, RC; Swinford-Jackson, SE; Unterwald, EM; Vanderschuren, LJMJ | 1 |
Grodin, EN; Ho, D; Ray, LA; Towns, B | 1 |
Burnette, EM; Green, R; Grodin, EN; Lim, AC; Miotto, K; Ray, LA | 1 |
Bold, KW; Fucito, LM; Gueorguieva, R; Haeny, AM; Montgomery, L; Muvvala, SB; O'Malley, SS; Wu, R; Zweben, A | 1 |
Chen, N; Guo, K; Li, J; Li, X; Li, Y; Yang, K | 1 |
McKee, SA; Moore, K; Oberleitner, L; Picciotto, MR; Roberts, W; Verplaetse, TL | 1 |
Fucito, L; O'Malley, SS; Piepmeier, ME; Zweben, A | 1 |
Dilley, JE; Filosa, NJ; Froehlich, JC; Nicholson, ER; Rademacher, LC; Smith, TN | 1 |
Higuchi, S; Matsushita, S; Mimura, M; Suzuki, T; Uchida, H; Ueno, F; Yokoyama, A | 1 |
Evins, AE; Kelly, JF | 1 |
Bold, KW; Fucito, LM; Gueorguieva, R; Jatlow, P; Muvvala, S; O'Malley, SS; Ockert, DM; Petrakis, I; Piepmeier, ME; Wu, R; Zweben, A | 1 |
Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Hurt, RT; Schroeder, DR | 1 |
McKee, SA; Roberts, W | 1 |
Lim, AC; Ray, LA; Roche, DJO | 1 |
Bold, KW; Fucito, LM; Gueorguieva, R; Muvvala, S; O'Malley, SS; Piepmeier, ME; Wu, R; Zweben, A | 1 |
Anton, RF; Falk, DE; Fertig, J; Hasin, DS; Johnson, B; Kranzler, HR; Litten, RZ; Mann, KF; Meulien, D; O'Malley, SS; Ryan, M; Slater, M; Witkiewitz, K | 1 |
Martin, RA; Rohsenow, DJ; Tidey, JW | 1 |
Abdul-Malak, Y; Ajagbe, TO; Batki, SL; Dimmock, JA; Meszaros, ZS; Wang, D | 1 |
Kampman, KM; Lynch, KG; O'Brien, CP; Pettinati, HM; Plebani, JG; Rennert, L | 1 |
Anton, RF; Henderson, S; Li, X; Myrick, H; Randall, PK; Schacht, JP | 1 |
Brody, A; Courtney, KE; Ghahremani, DG; London, ED; Miotto, K; Ray, LA | 1 |
Erwin, BL; Slaton, RM | 1 |
Ebert, S; Tetrault, JM | 1 |
Lieb, M; Soyka, M | 1 |
Higuchi, S; Kimura, M; Maesato, H; Matsushita, S; Mizukami, T; Nakayama, H; Sakuma, H; Takimura, T; Yokoyama, A; Yoneda, J; Yoshimura, A | 1 |
Asanovska, G; de Bejczy, A; Franck, J; Guterstam, J; Hammarberg, A; Isaksson, A; Löf, E; Söderpalm, B; Walther, L | 1 |
Aubin, HJ; Luquiens, A | 1 |
Klein, JW | 1 |
Dilley, JE; Filosa, NJ; Fischer, SM; Froehlich, JC; Nicholson, ER; Rademacher, LC; Smith, TN | 1 |
Nadeem, SS; Pirmoradi, P; Roshan, S | 1 |
Cocores, JA; Gold, MS | 1 |
Balchunas, E; Estevez, N; Harrison, EL; Krishnan-Sarin, S; McKee, SA; O'Malley, SS; Petrakis, IL; Picciotto, MR; Shi, J; Tetrault, JM | 1 |
Kuehn, BM | 1 |
Bartlett, SE; Chatterjee, S | 1 |
Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR | 1 |
Bartlett, SE; Fields, HL; Kayser, AS; Mitchell, JM; Teague, CH | 1 |
Gould, TJ; Gulick, D | 1 |
11 review(s) available for varenicline and Alcohol Abuse
Article | Year |
---|---|
Efficacy of Varenicline in the Treatment of Alcohol Dependence: An Updated Meta-Analysis and Meta-Regression.
Topics: Alcoholic Intoxication; Alcoholism; Craving; Ethanol; Humans; Randomized Controlled Trials as Topic; Varenicline | 2023 |
Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis.
Topics: Alcoholism; Antidepressive Agents; Bupropion; Humans; Network Meta-Analysis; Nortriptyline; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023.
Topics: Adolescent; Alcoholism; Bupropion; Female; Humans; Nicotinic Agonists; Pregnancy; Pulmonary Medicine; Smoking Cessation; Thoracic Surgery; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2023 |
Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials.
Topics: Alcoholism; Humans; Nicotinic Agonists; Patient Satisfaction; Randomized Controlled Trials as Topic; Varenicline | 2019 |
The Impact of Varenicline on Alcohol Consumption in Subjects With Alcohol Use Disorders: Systematic Review and Meta-Analyses.
Topics: Alcohol Drinking; Alcoholism; Humans; Nicotinic Agonists; Varenicline | 2020 |
The effects of pharmacological interventions on smoking cessation in people with alcohol dependence: A systematic review and meta-analysis of nine randomized controlled trials.
Topics: Alcoholism; Humans; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2021 |
Varenicline in the treatment of alcohol use disorders.
Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Disorder; Varenicline | 2014 |
Recent Developments in Pharmacotherapy of Alcoholism.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Anticonvulsants; Baclofen; Humans; Naltrexone; Narcotic Antagonists; Pharmacogenetics; Randomized Controlled Trials as Topic; Taurine; Varenicline | 2015 |
Feeding Two Birds with One Scone: The Case of Varenicline.
Topics: Alcoholism; Clinical Trials as Topic; Dopamine; Humans; Nicotinic Agonists; Smoking; Varenicline | 2015 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Benzazepines; Brain; Humans; Mecamylamine; Neurons; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline | 2010 |
20 trial(s) available for varenicline and Alcohol Abuse
Article | Year |
---|---|
Alcohol use disorder severity moderates clinical response to varenicline.
Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Craving; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality of Life; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2021 |
Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial.
Topics: Adult; Alcoholism; Alkaloids; Azocines; Benzazepines; Female; HIV Infections; Humans; Male; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.
Topics: Alcohol Drinking; Alcoholism; Double-Blind Method; Humans; Naltrexone; Treatment Outcome; Varenicline; World Health Organization | 2022 |
Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Craving; Cues; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Treatment Outcome; Varenicline; Young Adult | 2020 |
A novel human laboratory model for screening medications for alcohol use disorder.
Topics: Alcohol Drinking; Alcoholism; Humans; Laboratories; Naltrexone; Varenicline | 2020 |
The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.
Topics: Adult; Alcoholism; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Patient Satisfaction; Smoking; Smoking Cessation; Surveys and Questionnaires; Varenicline | 2017 |
Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.
Topics: Adult; Alcoholism; Combined Modality Therapy; Comorbidity; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Patient Care Team; Sex Factors; Smoking Cessation; Treatment Outcome; Varenicline | 2018 |
Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.
Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Smokers; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2018 |
Effects of varenicline on cognitive performance in heavy drinkers: Dose-response effects and associations with drinking outcomes.
Topics: Adult; Alcohol Drinking; Alcoholism; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Nicotinic Agonists; Reaction Time; Varenicline; Young Adult | 2018 |
Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking.
Topics: Adult; Alcoholism; Cigarette Smoking; Comorbidity; Double-Blind Method; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Smoking Cessation; Smoking Cessation Agents; Varenicline | 2019 |
Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
Topics: Adult; Alcohol Abstinence; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Middle Aged; Naltrexone; Risk Assessment; Topiramate; Varenicline | 2019 |
Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.
Topics: Adult; Alcoholism; Comorbidity; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Outcome Assessment, Health Care; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2019 |
Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence.
Topics: Adult; Affect; Alcoholism; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Quinoxalines; Sample Size; Smoking; Socioeconomic Factors; Treatment Outcome; Varenicline | 2013 |
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Brain; Brain Mapping; Craving; Cues; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motivation; Nicotinic Agonists; Pilot Projects; Quinoxalines; Reward; Varenicline; Young Adult | 2014 |
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.
Topics: Adult; Alcoholism; Benzazepines; Brain; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2015 |
Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Alcoholism; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Single-Blind Method; Sweden; Treatment Outcome; Varenicline | 2015 |
Varenicline reduces alcohol self-administration in heavy-drinking smokers.
Topics: Adult; Alcoholism; Benzazepines; Central Nervous System Depressants; Double-Blind Method; Ethanol; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Varenicline; Young Adult | 2009 |
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.
Topics: Adult; Aged; Aged, 80 and over; Alcoholism; Behavior Therapy; Benzazepines; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Temperance; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2011 |
Varenicline decreases alcohol consumption in heavy-drinking smokers.
Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Double-Blind Method; Drug Administration Schedule; Female; Health Records, Personal; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2012 |
17 other study(ies) available for varenicline and Alcohol Abuse
Article | Year |
---|---|
Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities.
Topics: Alcoholism; Anorexia Nervosa; Attention Deficit Disorder with Hyperactivity; Comorbidity; Humans; Mental Disorders; Methadone; Naltrexone; Narcotics; Patient Outcome Assessment; Schizophrenia; Smoking; Varenicline | 2021 |
S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short Version.
Topics: Adolescent; Alcoholism; Female; Humans; Pregnancy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2022 |
The Persistent Challenge of Developing Addiction Pharmacotherapies.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Drug Therapy; Humans; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Smoking Cessation Agents; Substance-Related Disorders; Varenicline | 2021 |
Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.
Topics: Alcohol Drinking; Alcoholism; Cues; Double-Blind Method; Humans; Naltrexone; Smokers; Varenicline | 2021 |
The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials.
Topics: Adult; Alcoholism; Cigarette Smoking; Double-Blind Method; Female; Humans; Male; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2021 |
Effects of varenicline on alcohol self-administration and craving in drinkers with depressive symptoms.
Topics: Adult; Alcohol Drinking; Alcoholism; Comorbidity; Craving; Depression; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Outcome Assessment, Health Care; Varenicline | 2017 |
Varenicline Reduces Alcohol Intake During Repeated Cycles of Alcohol Reaccess Following Deprivation in Alcohol-Preferring (P) Rats.
Topics: Alcohol Abstinence; Alcohol Drinking; Alcoholism; Animals; Ethanol; Male; Rats; Self Administration; Varenicline | 2017 |
Psychotic Symptoms Associated With Varenicline in a Patient With Alcohol and Nicotine Dependence: A Case Report.
Topics: Adult; Alcoholism; Humans; Male; Nicotinic Agonists; Psychoses, Substance-Induced; Tobacco Use Disorder; Varenicline | 2017 |
A Call to Action for Treatment of Comorbid Tobacco and Alcohol Dependence.
Topics: Alcoholism; Cigarette Smoking; Comorbidity; Humans; Nicotiana; Varenicline | 2018 |
Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
Topics: Adult; Alcohol Drinking; Alcoholism; Cigarette Smoking; Craving; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Random Allocation; Smokers; Smoking Cessation; Stress, Psychological; Varenicline; Young Adult | 2018 |
[Varenicline, an optional treatment for alcohol dependence syndrome in smokers or non-smokers].
Topics: Alcoholism; Benzazepines; Humans; Multicenter Studies as Topic; Nicotinic Agonists; Pilot Projects; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Varenicline | 2014 |
[Concurrent inpatient smoking cessation and alcohol abstinence programs for alcoholics and their outcomes].
Topics: Adult; Aged; Alcohol Abstinence; Alcoholism; Benzazepines; Cognitive Behavioral Therapy; Female; Humans; Inpatients; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline; Young Adult | 2014 |
Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.
Topics: Alcohol Drinking; Alcoholism; Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Models, Animal; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Rats; Rodentia; Treatment Outcome; Varenicline | 2016 |
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression.
Topics: Adult; Alcoholism; Benzazepines; Depressive Disorder, Major; Humans; Male; Mental Disorders; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Varenicline, appetite, and weight reduction.
Topics: Aged; Alcoholism; Benzazepines; Female; Humans; Psychiatric Status Rating Scales; Quinoxalines; Smoking Cessation; Varenicline; Weight Loss | 2008 |
Findings on alcohol dependence point to promising avenues for targeted therapies.
Topics: Alcoholism; Animals; Benzazepines; Humans; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Nicotinic Agonists; Pharmacogenetics; Pyridines; Quinoxalines; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, mu; Stress, Psychological; Triazoles; Varenicline | 2009 |
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice.
Topics: Acetylcholine; Alcoholism; Animals; Benzazepines; Central Nervous System Depressants; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Freezing Reaction, Cataleptic; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Quinoxalines; Smoking Cessation; Varenicline | 2008 |